Reverse Diabetes2 Now is officially recognized by the European Union as the first and only lifestyle treatment for people with type 2 diabetes

Reverse Diabetes2 Now is officially recognized by the European Union as the first and only lifestyle treatment for people with type 2 diabetes

Reverse Diabetes2 Now is officially recognized by the European Union as the first and only lifestyle treatment for people with type 2 diabetes. The successful program focuses on medication reduction and complete remission for patients with type 2 diabetes. The EU Health Council has officially designated the treatment as ‘best practice’ at the European level.¬†

The Health Council thoroughly examined Reverse Diabetes2 Now and rated it as a best practice to promote public health within Europe. The report shows that Reverse Diabetes2 Now is labeled as “highly relevant to public health in a high priority area. In addition, the programme features a strong evidence-based concept with clear SMART objectives, focused process protocols and impact evaluation’.

Reverse Diabetes2 Now is a multidisciplinary lifestyle treatment aimed at reversing type 2 diabetes, using nutrition, exercise, sleep and relaxation as medicine. Several major health insurers reimburse for the program, which is developed and implemented by scientists, physicians and other professionals.

Key findings EU
The report also states, among other things, that Reverse Diabetes2 Now is accessible to people of lower socioeconomic status through its low fees and reimbursement by insurers. This is an important aspect for the EU, as many other lifestyle treatments, due to the sometimes high fees charged, can increase inequality between income groups. This leaves those most affected by obesity/diabetes with less access to healthier choices.

Reverse Diabetes2 Now has also been labeled a best practice due to the good outcomes of participants. One year after starting the program, 92% have been reversed, meaning a participant is taking less or no medication and/or has healthier blood values (HbA1C). Data also shows that 24 months after starting the program, the percentage of participants who have been reversed remains stable, which is exceptional in regular diabetes care, there only a few percent manage to reverse. And 30% of participants even stop taking medication altogether.

Currently, research is being done on how Reverse Diabetes2 Now can be implemented and translated on an European level, looking at the differences in care systems and diets between countries. European countries that are interested in a pilot of Reverse Diabetes2 Now can email dirkjaap@voedingleeft.nl for more information and funding requests.